University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
60
presentations
5
followers
3
more
presentations
in this session
Novel thromboelastography point-of-care test detects all commercially available DOACs at therapeutic concentrations and classifies them as direct thrombin or factor Xa inhibitors with high consistency